Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Valentina Boasi"'
Autor:
Federico Vergni, Manfredi Arioti, Valentina Boasi, Federico Ariel Sánchez, Massimo Leoncini, Fabio Ferrari
Publikováno v:
REC: Interventional Cardiology (English Ed.), Vol 6, Iss 1, Pp 25-32 (2024)
ABSTRACT Introduction and objectives: Contrast-induced-acute kidney injury (CI-AKI) is a potential complication of angiographic procedures. The DyeVert Contrast Reduction system (Osprey Medical, United States) is a device to reduce the concentration
Externí odkaz:
https://doaj.org/article/51c7e9fc043a48358333256212fca94c
Autor:
Federico Vergni, Manfredi Arioti, Valentina Boasi, Federico Ariel Sánchez, Massimo Leoncini, Fabio Ferrari
Publikováno v:
REC: Interventional Cardiology, Vol 6, Iss 1, Pp 25-32 (2024)
RESUMEN Introducción y objetivos: La nefropatía inducida por contraste (NIC) es una potencial complicación de los procedimientos angiográficos. El sistema DyeVert Power (Osprey Medical, Estados Unidos) permite reducir la concentración renal del
Externí odkaz:
https://doaj.org/article/6a0721a9966b4ea5afe3f81e07bf381e
Autor:
Federico Sanchez, Valentina Boasi, Matteo Vercellino, Chiara Tacchi, Pierpaolo Cannarile, Nicoletta Pingelli, Dino Perri, Laura Gomez, Stefano Cattunar, Giovanni Mascelli
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background The PEGASUS-TIMI 54 trial inclusion criteria effectively identified high-risk patients with recent myocardial infarction (MI) who would benefit from continuing dual antiplatelet therapy (DAPT) with ticagrelor for more than 12 mont
Externí odkaz:
https://doaj.org/article/f58c70d9ba7a49aca6ed1db97016af2a
Autor:
Nicola Forni, Valentina Boasi, Katiuscia Sciole, Silvia Borile, Nicoletta Pingelli, Domenico Marra, Sara Tita Farinella, Giovanni Cenderello, Federico Ariel Sanchez
Publikováno v:
Geriatric Care, Vol 6, Iss 3 (2020)
The recent outbreak exposed doctors to a new challenge: treating people without any scientific evidence. All molecules combined in treatment schedules were merged on the basis of weak and anecdotal data so, the recommendations are constantly changing
Externí odkaz:
https://doaj.org/article/cbabd2521cc345c18a21b81d36f87f62
Autor:
Matteo Vercellino, Federico Ariel Sànchez, Valentina Boasi, Dino Perri, Chiara Tacchi, Gioel Gabrio Secco, Stefano Cattunar, Gianfranco Pistis, Giovanni Mascelli
Publikováno v:
BMC Cardiovascular Disorders, Vol 17, Iss 1, Pp 1-11 (2017)
Abstract Background European guidelines recommend the use of ticagrelor versus clopidogrel in patients with ST elevation myocardial infarction (STEMI). This recommendation is based on inconclusive results and subanalyses from clinical trials. Few dat
Externí odkaz:
https://doaj.org/article/b9fb1bf2dedf4d16944142f60634d43f
Autor:
Valentina Boasi
Publikováno v:
Journal of Cardiology & Cardiovascular Therapy. 16
Autor:
Giovanni Mascelli, Stefano Cattunar, Pierpaolo Cannarile, Nicoletta Pingelli, Federico Ariel Sanchez, Laura Gomez, Chiara Tacchi, Dino Perri, Valentina Boasi, Matteo Vercellino
Publikováno v:
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
Background The PEGASUS-TIMI 54 trial inclusion criteria effectively identified high-risk patients with recent myocardial infarction (MI) who would benefit from continuing dual antiplatelet therapy (DAPT) with ticagrelor for more than 12 months. It is
Autor:
Matteo Vercellino, E Bologna, D Bartolini, Valentina Boasi, Sandro Bellotti, Alessandro Iannone, M Bruzzone, Marco Fedele, P C Cannarile, Paolo Rubartelli, F Ariel Sanchez
Publikováno v:
European Heart Journal. 41
Background The negative prognostic effect of chronic kidney disease (CKD), anaemia and diabetes in patients with acute coronary syndromes is well known. However, data about the prevalence and the prognostic importance of these comorbidities in unsele
Autor:
Valentina Boasi, Katiuscia Sciole, Giovanni Cenderello, Federico Ariel Sanchez, Silvia Borile, Domenico Marra, Sara Tita Farinella, Nicola Forni, Nicoletta Pingelli
Publikováno v:
Geriatric Care, Vol 6, Iss 3 (2020)
The recent outbreak exposed doctors to a new challenge: treating people without any scientific evidence. All molecules combined in treatment schedules were merged on the basis of weak and anecdotal data so, the recommendations are constantly changing
Publikováno v:
European Heart Journal. 39